Skip to main content
SpringerLink
Log in

Boron Neutron Capture Therapy: Effects of Split Dose and Overall Treatment Time

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

New clinical protocols are being developed that will entail the administration of considerably higher doses of the boron delivery agent boronophenylalanine (BPA) than those in current clinical use. Fractionation (2 or 4 fractions) of BPA mediated boron neutron capture therapy (BNCT) is also under consideration at some clinical centres. Given the considerably higher infusion volumes that will be entailed in the delivery of BPA in the new high dosage protocols, there will be a requirement to extend the gap between fractions to 2 or more days. In order to assess the effects of a 2 fraction protocol on the therapeutic efficacy of BPA mediated BNCT, a series of split dose irradiations (two equal fractions) were undertaken using the rat intracranially implanted 9L gliosarcoma model. A single dose exposure to BPA mediated BNCT of 3.0 Gy resulted in long term survival levels of 50%. Survival levels increased to 71% and 77% with a 3 and 5 day gap between dose fractions (two equal fractions), respectively, using the same total dose. A further increase in the time interval between dose fractions to 7 days resulted in a reduction in survival to 36%. However, there was no significant difference between the single dose and the 3, 5 and 7 day survival data (P > 0.1) The difference between the 5 and 7 day split dose survival data was of border-line significance (P = 0.05). It is anticipated that mucositis, could become a potential problem in future BNCT clinical protocols involving higher doses, larger field sizes or multiple fields. The potential sparing of the oral mucosa, due to repopulation during the interval between the two fractions, was investigated using a series of split dose BPA mediated BNC irradiations. The ventral surface of the rat tongue was utilised as a model for oral mucosa. The ED50 (50% incidence) values for the ulceration end point were 3.0±0.1,3.2±0.1,3.0±0.1 and 3.6±0.1 Gy, for 3, 5, 7 and 9 day splits between doses, respectively. It is evident from this data that there were no significant changes in the ED50 (p < 0.001) until the 9 day dose split, when the ED50 value was 20% higher than the ED50 value after a 7 day split. It was concluded that the two fraction BNCT protocol, with dose splits of up to 5 days, did not diminish the therapeutic response of the rat 9L gliosarcoma, when compared with a single dose BNCT protocol. Tolerance of the oral mucosa to BNC irradiation was not increased until there was a 9 day gap between fractions. However, the beneficial effects of dose sparing at this time interval between doses, would probably be counteracted by a reduction in the therapeutic effectiveness of the BNCT modality, due to repopulation of tumour clonogens between doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Joel DD, Fairchild RG, Laissue JA, Saraf SK, Kalef-Ezra JA, Slatkin DN: Boron neutron capture therapy for intracerebral rat gliosarcomas. Proc Natl Acad Sci USA 87: 9808–9812, 1990

    Google Scholar 

  2. Coderre JA, Joel DD, Micca PL, Nawrocky MM, Slatkin DN: Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine. Radiat Res 129: 290–296, 1992

    Google Scholar 

  3. Coderre JA, Button TM, Micca PL, Fisher CD, Nawrocky MM, Liu HB: Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int J Radiat Oncol Biol Phys 30: 643–652, 1994

    Google Scholar 

  4. Coderre JA, Bergland R, Capala J, Chadha M, Chanana AD, Elowitz E, Joel DD, Liu HB, Slatkin DN: Boron neutron capture therapy for glioblastoma multiform using p-boronophenylalanine and epithermal neutrons: Trial design and early clinical results. J Neuro-Oncol 33: 141–152, 1997

    Google Scholar 

  5. Parkins C, Fowler JF, Shen Y: A murine model of lip epidermal/mucosal reactions to X-irradiation. Radiother Oncol 1: 159–165, 1983

    Google Scholar 

  6. Moses R, Kummermehr J: Radiation response of the mouse tongue epithelium. Brit J Cancer 53: Suppl VII, 12–15, 1986

    Google Scholar 

  7. Coderre JA, Morris GM, Micca PL, Ma RM, Gordon CR: The effects of boron neutron capture irradiation on oral mucosa: evaluation using a rat tongue model. Radiat Res 152: 113–118, 1999

    Google Scholar 

  8. Gillespie GM: Renewal of buccal epithelium. Oral Surgery 27: 83–89, 1969

    Google Scholar 

  9. Brown JM: The effects of acute X-irradiation on the cell proliferation kinetics of induced carcinomas and their normal counterpart. Radiat Res 43: 627–653, 1970

    Google Scholar 

  10. Morris GM, Landuyt W, Whitehouse E, Vanuytsel L, Hopewell JW: Radiation response of mouse lip mucosal epithelium: a cell kinetic study. Int J Radiat Biol 63: 509–517, 1993

    Google Scholar 

  11. Dorr W, Kummermehr J: Proliferation kinetics of mouse tongue epithelium under normal conditions and following single dose irradiation. Virchows Archives B 60: 287–293, 1991

    Google Scholar 

  12. Dorr W, Emmendorfer H, Weber-Frisch M: Tissue kinetics in mouse tongue mucosa during daily fractionated radiotherapy. Cell Prolif 29: 495–504, 1996

    Google Scholar 

  13. Ang KK, Xu FX, Vanuytsel L, Schueren Van Der E: Repopulation kinetics in irradiated mouse lip mucosa: the relative importance of treatment protraction and time distribution of irradiations. Radiat Res 101: 162–169, 1985

    Google Scholar 

  14. Dorr W, Kummermehr J: Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses. Radiother Oncol 17: 249–259, 1990

    Google Scholar 

  15. Xu F, Van Der Schueren E, Ang KK: Acute reactions of the lip mucosa of mice to fractionated irradiations. Radiother Oncol 1: 369–374, 1984

    Google Scholar 

  16. Morris GM, Coderre JA, Hopewell JW, Micca PL, Rezvani M: Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium. Radiother Oncol 39: 253–259, 1994

    Google Scholar 

  17. Yoshino K, Suzuki A, Mori H, Kanihana C, Honda C, Mishima Y, Kobayashi T, Kanda K: Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides. Stralanther Oncol 165: 127-129, 1989

    Google Scholar 

  18. Fairchild RG, Gabel D, Laster BH, Greenberg D, Kiszenick W, Micca PL: Microanalytical techniques for boron analysis using the 10B(n,α)7Li reaction. Med Phys 13: 50–56, 1986

    Google Scholar 

  19. Morris GM, Smith DW, Patel H, Hopewell JW, Rezvani M, Micca PL, Coderre JA: Boron microlocalisation in oral mucosal tissue: implications for boron neutron capture therapy. Br J Cancer 82: 1764–1771, 2000

    Google Scholar 

  20. Coderre JA, Morris GM, Micca PL, Fisher CD, Ross GA: Comparative assessment of single-dose and fractionated boron neutron capture therapy. Radiat Res 144: 310–317, 1995

    Google Scholar 

  21. Morris GM, Coderre JA, Hopewell JW, Rezvani M, Micca PL, Fisher CD: Response of the central nervous system to fractionated boron neutron capture irradiation: studies with borocaptate sodium. Int J Radiat Biol 71: 185–192, 1997

    Google Scholar 

  22. Gavin PR, Kraft SL, Huiskamp R, Coderre JA: CNS effects and normal tissue tolerance in dogs (a review). J Neuro-Oncol 33: 71–80, 1997

    Google Scholar 

  23. Asai A, Shibui S, Barker M, Vanderlaan M, Gray JW, Hoshino T: Cell kinetics of rat 9L brain tumours determined by double labelling with iodo-and bromodeoxyuridine. J Neurosurg 73: 254–258, 1990

    Google Scholar 

  24. Kabalka GW, Smith GT, Dyke JP, Reid WS, Longford CPD, Roberts TG, Reddy NK, Buonocore E, Hubner KFC: Evaluation of fluorine-18 BPA fructose for boron neutron capture treatment planning. J Nucl Med 38: 1762–1767, 1997

    Google Scholar 

  25. Imahori Y, Ucda Y, Ohmori T, Kusuki T, Ono K, Fujii R, Ido T: Fluorine-18 labelled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med 39: 325–333, 1998

    Google Scholar 

  26. Smith DR, Chandra S, Coderre JA, Morrison GH: Ion microscopy imaging of 10B from p-boronophenylalanine in a brain tumour model for boron neutron capture therapy. Cancer Res 56: 4302–4306, 1996

    Google Scholar 

  27. Dutreix J, Tubiana M, Wambersie A, Malaise E: The influence of cell proliferation in tumours and normal tissues during fractionated radiotherapy. Eur J Cancer 7: 205–213, 1971

    Google Scholar 

  28. Maxymin WG and Wood RE: The role of dentistry in head and neck radiation therapy. J Can Dent Assoc 55: 193–198, 1989

    Google Scholar 

  29. van der Schueren E, van der Bogaert W, Ang KK: Radiotherapy with multiple fractions per day. In: Steel GG, Adams G, Peckam M (eds) The Biological Basis of Radiotherapy. Elsevier Science, Amsterdam. 1983, pp 195–210

    Google Scholar 

  30. Spiijkervet FKL, Saene HKF, Panders AK, Vermey A, Mehta DM: Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med 18: 167–171, 1989

    Google Scholar 

  31. Dorr W: Repopulation in mouse oral mucosa: treatment splits. Radiother Oncol 33: 139–147, 1994

    Google Scholar 

  32. Hall EJ: Time, Dose and Fractionation in Radiotherapy. In: Radiobiology for the Radiologist. JB Lippincott Company, Philadelphia, 1988, pp 239–259

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Churchill Hospital, Research Institute (University of Oxford), Oxford, Headington, UK

    G.M. Morris, M. Rezvani & J.W. Hopewell

  2. Medical Department, Brookhaven National Laboratory, Upton, NY, USA

    P.L. Micca & J.A. Coderre

Authors
  1. G.M. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P.L. Micca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Rezvani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J.W. Hopewell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J.A. Coderre
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morris, G., Micca, P., Rezvani, M. et al. Boron Neutron Capture Therapy: Effects of Split Dose and Overall Treatment Time. J Neurooncol 52, 101–110 (2001). https://doi.org/10.1023/A:1010689822493

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010689822493

Search

Navigation